Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.16, sa.11, ss.1519-1524, 2012 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 16 Sayı: 11
- Basım Tarihi: 2012
- Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1519-1524
- Anahtar Kelimeler: Rosiglitazone, Insulin resistance, Chronic kidney disease, TNF-alpha, NECROSIS-FACTOR-ALPHA, C-REACTIVE PROTEIN, HOMEOSTASIS MODEL ASSESSMENT, BLOOD-PRESSURE VARIABILITY, WAIST CIRCUMFERENCE, INFLAMMATION, ASSOCIATION, PREVALENCE, RISK, SENSITIVITY
- Akdeniz Üniversitesi Adresli: Hayır
Özet
AIM: The aim of the study was to investigate the effects of rosiglitazone treatment on insulin resistance (IR) and tumor necrosis factor-alpha (TNF-alpha) levels in nondiabetic chronic kidney disease (CKD) patients with IR.